Galen Growth Asia CEO and founder Julien de Salaberry shares key trends and insights on the second largest and fastest growing digital health ecosystem in the world.
Many pharma companies talk about the importance of ‘patient centric’ clinical trials and involving patients in trial design – but what does this really mean?
Healthcare professionals (HCPs) strive to give their patients the best possible care and treatment, but it’s a tough job and, inadvertently, ingrained beliefs and behaviours can sometimes g
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
